Newly diagnosed versus relapsed idiopathic thrombotic thrombocytopenic purpura: a comparison of presenting clinical characteristics and response to treatment-Reference-Cited by-同舟云学术

Newly diagnosed versus relapsed idiopathic thrombotic thrombocytopenic purpura: a comparison of presenting clinical characteristics and response to treatment

Published:2009-02-11 Issue:10 Volume:88 Page:973-978
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Alvarez-Larrán Alberto,del Río-Garma Julio,Pujol Misericòrdia,de la Rubia Javier,Hernández-Jodra Manuel,Borrell Montserrat,González-Porras José R.,García-Gala José M.,Viejo Aurora,Enríquez Lourdes,Arbona Cristina,García-Erce José A.,Noblejas Ana G.,Pereira Arturo

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00277-009-0707-9.pdf

Reference25 articles.

1. Aqui NA, Stein SH, Konkle BA, Abrams CS, Strobl FJ (2003) Role of splenectomy in patients with refractory or relapsed thrombotic thrombocytopenic purpura. J Clin Apher 18:51–54. doi: 10.1002/jca.10053

2. Bianchi V, Robles R, Alberio L, Furlan M, Lammle B (2002) Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura. Blood 100:710–713. doi: 10.1182/blood-2002-02-0344

3. Cohen JA, Brecher ME, Bandarenko N (1998) Cellular source of serum lactate dehydrogenase elevation in patients with thrombotic thrombocytopenic purpura. J Clin Apher 13:16–19. doi: 10.1002/(SICI) 1098-1101(1998) 13:1<16::AID-JCA3>3.0.CO;2-C

4. Del Rio-Garma J, Alvarez-Larran A, Martinez C, Muncunill J, Castella D, de la RJ et al. (2008) Methylene blue-photoinactivated plasma versus quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: a multicentric, prospective cohort study. Br J Haematol 143:39–45

5. Dervenoulas J, Tsirigotis P, Bollas G, Pappa V, Xiros N, Economopoulos T et al (2000) Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS): treatment outcome, relapses, prognostic factors. A single-center experience of 48 cases. Ann Hematol 79:66–72. doi: 10.1007/s002770050012

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Largest comparison between onset and relapses of acquired thrombotic thrombocytopenic purpura reveals severe neurological involvement and worse analytic parameters at debut;Annals of Hematology;2024-01-27

2. Immune thrombotic thrombocytopenic purpura in older patients: Results from the Spanish TTP Registry (REPTT);British Journal of Haematology;2023-09-18

3. Spanish registry of thrombotic thrombocytopenic purpura (REPTT): Data evidence and new developments;Transfusion and Apheresis Science;2023-06

4. Long-term risk of relapse in immune-mediated thrombotic thrombocytopenic purpura and the role of anti-CD20 therapy;Blood;2023-01-19

5. Application of the French TMA Reference Center Score and the mortality in TTP Score in de novo and relapsed episodes of acquired thrombotic thrombocytopenic purpura at a tertiary care facility in Spain;Journal of Clinical Apheresis;2021-02-03